Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Piramal Pharma Invests $90 Million to Expand U.S. Manufacturing Facilities
Piramal Pharma Solutions is investing $90 million to expand two US facilities, aimed at boosting manufacturing capacity and improving operational efficiency This move supports the companys integrated antibodydrug conjugate
Hikma Invests $1 Billion to Expand its Manufacturing and R&D Operations
Hikma Pharmaceuticals USA has unveiled a strategic plan to invest $1 billion by the year 2030 to expand its manufacturing and research capabilities within the United States This major investment is designed to bolster
Orano Med invests $5 Million to Expand R&D Centre in Texas
Orano Med, a branch of the Orano Group focused on radioligand cancer therapies, has revealed plans to expand its primary RD facility in Plano, Texas, backed by an investment exceeding $5 million
UCB invests $5 billion to Establish New Biologics Manufacturing Facility in the United States
Global biopharmaceutical company UCB has announced plans to build a new advanced biologics manufacturing facility in the United States This strategic investment aims to support the companys expanding presence
Roche and Genentech invest $700+ million in new North Carolina manufacturing facility
Genentech, a subsidiary of the Roche Group, has revealed plans to invest more than $700 million in constructing a new, cuttingedge drug manufacturing facility in Holly Springs, North Carolina
Novartis Invests $23 Billion to Expand U.S. Manufacturing and R&D Infrastructure
Novartis has announced plans to invest $23 billion over the next five years to strengthen its infrastructure in the United States The investment will ensure that all key medicines for US patients are manufactured domestically
Roche Expands U.S. Operations with $50 Billion Strategic Investment
Roche has announced a major investment of USD 50 billion in the United States, aimed at expanding its presence nationwide This move will strengthen Roches already substantial footprint in the US, which currently includes 13 manufacturing sites and 15 RD facilities across its Pharmaceuticals and Diagnostics divisions
Merck Announces $1 Billion Investment to Expand Vaccine Production Facility
Merck has inaugurated a cuttingedge vaccine manufacturing facility at its Durham, North Carolina site This $1 billion, 225,000squarefoot expansion is part of the companys broader initiative to enhance domestic production and research capabilities
Johnson & Johnson Sets $55B Investment Plan to Build Next-Gen Manufacturing Facilities
Johnson Johnson has announced plans to invest more than $55 billion in the United States over the next four years This marks a 25 percent increase compared to the companys previous fouryear investment period
CordenPharma Invests >€1 billion to Expand its Greenfield Facility
CordenPharma has announced plans to invest more than 1 billion over the next three years to build and expand peptide manufacturing facilities across Europe and the United States
